证券代码：601969 证券简称：海南矿业 公告编号：2025-088 海南矿业股份有限公司 关于持股 5%以上股东权益变动暨无偿划转股份的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次权益变动系海南矿业股份有限公司（以下简称"公司"）持股 5%以上 股东海南海钢集团有限公司（以下简称"海钢集团"）拟将其所持有的公司股份 100,939,000 股（占公司总股本 5.05%）无偿划转至海南省国有资本运营有限公司 （以下简称"海南国资运营"）。本次权益变动属于国有股份无偿划转，不涉及 要约收购。 本次权益变动后，海钢集团持有公司股份数量由 598,058,679 股（占公司 总股本 29.92%）减少至 497,119,679 股（占公司总股本 24.87%），海南国资运 营持有公司股份数量由 0 股增加至 100,939,000 股（占公司总股本 5.05%）。 本次国有股份无偿划转的实施不会导致公司控股股东及实际控制人发生 变更，不会对公司正常生产经营活动产生不利影响。 本次无偿划转尚未完成 ...

Core Viewpoint - Hainan Mining has experienced a slight decline in stock price, with significant developments regarding loans and share pledges that may impact its financial position and operations [1][2][4]. Company Announcements - Hainan Mining's subsidiary, Roc Oil Company Pty Limited, has applied for a loan of 600 million RMB from China Merchants Bank and up to 200 million USD from a syndicate of banks, aimed at financing the acquisition of Tethys Oil AB shares and supporting new project capital expenditures and operational funds [1][4]. - The loans will be secured by various assets, including the entire equity of Tethys and Roc Oil's subsidiaries [1]. Shareholder Changes - As of the announcement date, the controlling shareholder, Shanghai Fosun High Technology (Group) Co., Ltd., holds 949,056,507 shares, representing 47.48% of the total shares, with 700 million shares pledged, accounting for 73.76% of its holdings and 35.02% of the total shares [2][4]. - On July 2, 2025, Fosun pledged 350 million shares to China Resources Deep National Investment Trust Co., Ltd., with a pledge period from July 1, 2025, to June 12, 2027, for debt repayment purposes [2]. Share Buyback Progress - As of June 30, 2025, Hainan Mining has not yet implemented its share buyback plan, which aims to repurchase shares at a maximum price of 10.12 RMB per share, with a total buyback fund between 75 million and 150 million RMB [3][4].

关注公众号，点击公众号主页右上角" ··· "，设置星标 "⭐" ，关注 鑫椤锂电 资讯~ -广告- 本文来源： #鑫椤锂电 富临精工公告，公司与四川发展龙蟒签署《合作框架协议》，双方将开展股权与资本合作，共同投资设立 合资公司，新建高压实密度磷酸铁锂正极材料项目与前驱体项目。 合资公司拟新建10万吨/年高压密磷酸 铁锂项目和10万吨/年磷酸二氢锂前驱体项目，选址于绵竹市德阳—阿坝生态经济产业园。 锂电材料端市场情况 行业热点 I C C S I N O 2025H1磷酸铁锂市场盘点：上半年产量同比增长66.6% 根据ICC鑫椤锂电统计， 2025年上半年磷酸铁锂产量163.2万吨，同比增长66.6%。 企业份额来看：湖南裕 能市场份额约30%，龙头地位显著，位于第一梯队；万润新能、德方纳米、友山科技、富临升华、常州锂 源市场份额在5%-10%之间，位于第二梯队。产量增速来看：TOP10企业中安达科技、当升科技增速最 高，均超过200%；友山科技、富临升华、国轩高科均超过100%；万润新能、泰丰先行也均超过80%；湖 南裕能虽然基数大，但也实现了超过40%的增幅。从发展潜力来看：除了湖南裕能、富临升华等综合实 ...

Core Viewpoint - Hainan Mining Co., Ltd. announced that its controlling shareholder, Fosun High Technology (Group) Co., Ltd., has pledged part of its shares to China Resources Deep National Investment Trust Co., Ltd. [2][5] Summary by Sections Share Pledge Details - As of the announcement date, Fosun High Technology has pledged 350,000,000 shares, which accounts for 36.88% of its total shareholding and 17.51% of the company's total shares [3][4] - The financing balance corresponding to this pledge is 500 million yuan [4] Shareholder Pledge Situation - The cumulative pledged shares by Fosun High Technology exceed 50% of its total shareholding in the company [3] Financial Stability and Impact - Fosun High Technology has the financial capability to repay the pledged shares, with repayment funds sourced mainly from its own and self-raised funds [5] - The share pledge will not affect the company's main business, financing credit, financing costs, or ongoing operational capabilities [5] - The pledge will not impact corporate governance, as the controlling shareholder and the company remain independent in terms of property, business, assets, and personnel [5]

证券代码：601969 证券简称：海南矿业 公告编号：2025-086 海南矿业股份有限公司 一、回购股份的基本情况 海南矿业股份有限公司（以下简称"公司"）于 2025 年 3 月 12 日召开 2025 年第二次临时股东大会，审议通过了《关于以集中竞价交易方式回购股份方案的 议案》，同意公司以自有资金和股票回购专项贷款通过集中竞价交易方式回购公司 发行的人民币普通股（A 股）股票，回购价格上限为人民币 10.12 元/股，回购资 金总额不低于人民币 7,500 万元（含）且不超过人民币 15,000 万元（含）。回购 期限为自公司 2025 年第二次临时股东大会审议通过回购方案之日起不超过 12 个 月，本次回购股份价格上限不超过人民币 10.04 元/股（含）。 具体内容详见公司于 2025 年 3 月 15 日披露的《关于以集中竞价交易方式回 购股份的回购报告书》（公告编号：2025-037）。 二、实施回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，上市公司应当在每个月的前 3 个交易日内公告截 至上月末的回购进展情况，现将公司 ...

证券代码：601969 证券简称：海南矿业 公告编号：2025-087 海南矿业股份有限公司 关于控股股东股份质押公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 截至本公告日，海南矿业股份有限公司（以下简称"公司"）控股股东上海 复星高科技（集团）有限公司（以下简称"复星高科"）持有公司股份 949,056,507 股，占公司股份总数的 47.48%；累计质押公司股份（含本次） 700,000,000 股，占其所持公司股份数的 73.76%，占公司股份总数的 35.02%。 一、上市公司股份质押 单位：股 股东名称 是否为 控股股 东 本次质押股 数 是否为 限售股 是否 补充 质押 质押起 始日 质押到期 日 质权人 占其所 持股份 比例 （%） 占公司 总股本 比例 （%） 质押融 资资金 用途 复星高科 是 350,000,000 否 否 2025 年 7 月 1 日 2027 年 6 月 12 日 华润深 国投 36.88 17.51 偿还债 务 二、上市公司控股股东股份质押情况 截至本公告披露日 ...

证券代码：601969 证券简称：海南矿业 海南矿业股份有限公司 2025 年第二季度投资者关系活动事项纪要 编号：2025-002 海南矿业股份有限公司（以下简称"公司"）2025 年第二季度与投资者在 信息披露范围内互动交流情况主要为: 召开 2 场网上业绩说明会；与投资者进行 "一对一"或"一对多"沟通交流及参加券商策略会等共 14 次，主要交流机构 包括新加坡政府投资公司、南方基金、汇华理财、富国基金等；接待个人投资者 来访 1 次；接听投资者来电 59 次；在上证 e 互动"问答"栏目回复投资者提问 12 次；投资者关系微信公众号"海南矿业投资者关系"发布公司动态 35 条；投 资者关系视频号"海南矿业投资者关系"发布视频 5 条。 投资者主要关注八角场气田最新产量水平、八角场气田天然气售价和成本、 氢氧化锂项目进展、油气业务的生产经营模式等方面。 | 序号 | 沟通方式 | 次数 | | --- | --- | --- | | 1 | 网上业绩说明会 | 2 | | 2 | "一对一"或"一对多"沟通交流及策略会 | 14 | | 3 | 接待个人投资者来访 | 1 | | 4 | 接听投资者咨询 ...

Report Summary 1. Industry Investment Rating - Not provided in the content 2. Core View - The spot trading of lithium carbonate is sluggish, and it is operating in a weak and volatile manner. The trend strength of lithium carbonate is -1, indicating a bearish view [1][3] 3. Summary by Relevant Catalogs Fundamental Tracking - **Futures Contracts**: For the 2507 contract, the closing price is 62,980, the volume is 955, and the open interest is 10,845. For the 2509 contract, the closing price is 62,780, the volume is 398,387, and the open interest is 326,676 [1] - **Basis and Other Data**: The basis between the spot and 2507 contract is -1,680, and between the spot and 2509 contract is -1,480. The difference between battery - grade and industrial - grade lithium carbonate is 1,600 [1] - **Raw Materials and Lithium Salts**: The price of spodumene concentrate (6%, CIF China) is 625, and battery - grade lithium carbonate is 61,300. Other lithium salts and related products also have corresponding price data [1] Macro and Industry News - SMM's battery - grade lithium carbonate index price is 61,332 yuan/ton, down 61 yuan/ton from the previous working day. Battery - grade and industrial - grade lithium carbonate prices remained flat compared to the previous working day [1] - Hainan Mining signed a spodumene off - take agreement with LMLB. Starting from January 1, 2026, LMLB will sell all the spodumene produced in the first phase of the Bugoni lithium mine project to Hainan Mining, which is an important step in its industrial layout [3]

Battery - Foton Motor has begun mass application of semi-solid batteries in its self-developed 24V starting lithium batteries, which are installed in its electric light trucks [2] - Beijing Chunzhi New Energy Technology Co., Ltd. launched a pilot project for electric bicycle battery swapping using all-solid-state batteries, marking the transition of its products from laboratory to commercial application [6] Materials - Zhongke Chuncui Technology successfully completed a Pre-A round of financing, which will be used to optimize new extraction agents for strategic metals and establish production projects for battery-grade lithium chloride and lithium dihydrogen phosphate [8] - Enjie Co., Ltd. announced that its subsidiary has begun mass shipments of high-purity lithium sulfide products, while another subsidiary is advancing the construction of a pilot project for solid-state electrolyte with a capacity of thousands of tons [10] - Hainan Mining signed a lithium spodumene off-take agreement with its subsidiary, ensuring that all spodumene produced from the Bukuni lithium mine project will be sold to Hainan Mining starting January 1, 2026 [11] - Yunnan Zhongke Xingcheng Graphite Co., Ltd. is set to construct a project with an annual production capacity of 100,000 tons of lithium battery anode materials, with a total investment of 2.5 billion yuan [13]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]